Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD

by Andreucci, A., Bulychev, A., Dale, E., Hu, X.S, Iwamoto, N., Lamore, S., Lin, X., Liu, F., Liu, Y., Mohapatra, S., Patil, S., Purcell-Estabrook, E., Taborn, K., Vargeese, C., Yang, H., Yin, Y.
Published 2022

miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways

by Cai, Z., Guo, S., Jiang, H., Li, Z., Liu, J., Liu, R., Wang, L., Zeng, L., Zhang, J.
Published 2022

AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome

by Augusto, J., Campbell, A., Conroy, R.M, Henshall, D.C, Jensen, M.A, Kesavan, J.C, Kielpinski, L., Kremer, T., Langa, E., Miller, M.T, Morris, G., Nguyen, N.T, Reschke, C.R, Sanfeliu, A., Worm, J.
Published 2022